Skip to content
2000
Volume 30, Issue 5
  • ISSN: 1381-6128
  • E-ISSN: 1873-4286

Abstract

Gynecologic cancers are among the most common malignancies with aggressive features and poor prognosis. Tumorigenesis in gynecologic cancers is a complicated process that is influenced by multiple factors, including genetic mutations that activate various oncogenic signaling pathways, including the TGF-β pathway. Aberrant activation of TGF-β signaling is correlated with tumor recurrence and metastasis. It has been shown that non-coding RNAs (ncRNAs) have crucial effects on cancer cell proliferation, migration, and metastasis. Upregulation of various ncRNAs, including long non-coding RNAs (lncRNA) and microRNAs (miRNAs), has been reported in several tumors, like cervical, ovarian, and endometrial cancers, but their cellular mechanisms remain to be investigated. Thus, recognizing the role of ncRNAs in regulating the TGF-β pathway may provide novel strategies for better treatment of cancer patients. The present study summarizes recent findings on the role of ncRNAs in regulating the TGF-β signaling involved in tumor progression and metastasis in gynecologic cancers.

Loading

Article metrics loading...

/content/journals/cpd/10.2174/0113816128284380240123071409
2024-02-01
2025-05-11
Loading full text...

Full text loading...

/content/journals/cpd/10.2174/0113816128284380240123071409
Loading

  • Article Type:
    Review Article
Keyword(s): Gynecologic cancers; lncRNA; miRNA; oncogenic signaling pathways; TGF-β; tumorigenesis
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test